ZNF345 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.152160E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.668800E-01
Normal-vs-Stage2
1.367620E-02
Normal-vs-Stage3
2.180500E-02
Normal-vs-Stage4
1.608960E-01
Stage1-vs-Stage2
3.556600E-01
Stage1-vs-Stage3
1.144840E-01
Stage1-vs-Stage4
7.516600E-01
Stage2-vs-Stage3
1.291210E-01
Stage2-vs-Stage4
7.558600E-01
Stage3-vs-Stage4
8.911900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.202400E-02
Normal-vs-AfricanAmerican
4.788300E-02
Normal-vs-Asian
1.410780E-01
Caucasian-vs-AfricanAmerican
6.206400E-01
Caucasian-vs-Asian
7.842800E-01
AfricanAmerican-vs-Asian
6.417800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.718150E-02
Normal-vs-Female
9.744000E-03
Male-vs-Female
4.657000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.614400E-01
Normal-vs-Age(41-60Yrs)
6.260500E-02
Normal-vs-Age(61-80Yrs)
4.741700E-03
Normal-vs-Age(81-100Yrs)
1.740180E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.792800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.969370E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.486050E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.506000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.116190E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.796400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.695600E-02
Normal-vs-Daily Drinker
3.884200E-02
Normal-vs-Weekly Drinker
1.919650E-02
Normal-vs-Occasional Drinker
6.916300E-02
Normal-vs-Social Drinker
2.359700E-02
Non Drinker-vs-Daily Drinker
9.784400E-01
Non Drinker-vs-Weekly Drinker
9.893400E-01
Non Drinker-vs-Occasional Drinker
5.451000E-01
Non Drinker-vs-Social Drinker
6.173600E-01
Daily Drinker-vs-Weekly Drinker
9.698600E-01
Daily Drinker-vs-Occasional Drinker
5.464000E-01
Daily Drinker-vs-Social Drinker
6.055400E-01
Weekly Drinker-vs-Occasional Drinker
5.715000E-01
Weekly Drinker-vs-Social Drinker
5.962000E-01
Occasional Drinker-vs-Social Drinker
9.083000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.477430E-01
Normal-vs-Grade 2
7.493700E-02
Normal-vs-Grade 3
6.324200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.349000E-01
Grade 1-vs-Grade 3
6.039400E-01
Grade 1-vs-Grade 4
1.477430E-01
Grade 2-vs-Grade 3
8.463600E-01
Grade 2-vs-Grade 4
7.493700E-02
Grade 3-vs-Grade 4
6.324200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.344000E-03
Normal-vs-NonDiabetic
1.310060E-02
Diabetic-vs-NonDiabetic
2.815400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.208100E-02
Normal-vs-NoPancreatitis
6.302800E-03
Pancreatitis-vs-NoPancreatitis
6.887400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.220170E-02
Normal-vs-N1
1.100410E-02
N0-vs-N1
4.570800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.195800E-02
Normal-vs-TP53-NonMutant
1.497180E-01
TP53-Mutant-vs-TP53-NonMutant
2.844800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
